title: Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses.
abstract: Pyoderma gangrenosum, a dramatic ulcerative skin disease, and Sweet syndrome, a papular dermatosis, were described independently. It was subsequently shown that they share many characteristics, including clinical overlap and the frequent association with multisystemic disorders. The group of the neutrophilic dermatoses encompasses these two dermatoses, as well as other conditions having in common an aseptic neutrophilic infiltrate predominating in the epidermis and/or the dermis and/or the subcutis. Some patients also experience neutrophilic infiltrates in other organs, defining the neutrophilic disease. Recent research suggests that the neutrophilic dermatoses could be considered as the cutaneous expression of the autoinflammation, an aberrant hyperproduction of interleukin-1. Autoinflammation is responsible for monogenic diseases, and is also involved in the mechanism of many polygenic conditions, including the neutrophilic dermatoses.
authors.affiliation: Médecin (hon). des Hôpitaux, Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: Wallach
authors.affiliation: Université Paris Diderot, Sorbonne Paris Cité, UMR-S 1165, F-75010, Paris, France.|INSERM, U1165, F-75010, Paris, France.|Laboratoire de Pathologie, Hôpital Saint-Louis, AP-HP, F-75010, Paris, France.
authors.forename: M-D
authors.initials: MD
authors.lastname: Vignon-Pennamen
mesh_terms: D003875:Drug Eruptions / Q000209:etiology; D006801:Humans; D011183:Postoperative Complications / Q000209:etiology / Q000473:pathology; D011379:Prognosis; D017511:Pyoderma Gangrenosum / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D016463:Sweet Syndrome / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*